Expression of potential cancer stem cell marker ABCG2 is associated with malignant behaviors of hepatocellular carcinoma

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Zhang, Guang ^a,b   Wang, Zhongxia ^a,c   Luo, Weihuan ^a   Jiao, Hongbo ^a   Wu, Junhua ^c   Jiang, Chunping ^a,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; DOXORUBICIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CANCER STEM CELL; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RNA INTERFERENCE; TUMOR VOLUME;

EID: 84886675130     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/782581     Document Type: Article

References (47)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Bruix J., Sherman M., Management of hepatocellular carcinoma: an update. Hepatology 2011 53 3 1020 1022 2-s2.0-79952231921 10.1002/hep.24199
3. Forner A., Reig M. E., Rodriguez de Lope C., Bruix J., Current strategy for staging and treatment: the BCLC update and future prospects. Seminars in Liver Disease 2010 30 1 61 74 2-s2.0-77349124041 10.1055/s-0030-1247133
4. Forner A., Llovet J. M., Bruix J., Hepatocellular carcinoma. The Lancet 2012 379 9822 1245 1255 2-s2.0-84859212951 10.1016/S0140-6736(11)61347-0
5. Jordan C. T., Guzman M. L., Noble M., Cancer stem cells. The New England Journal of Medicine 2006 355 12 1253 1261 2-s2.0-33748891391 10.1056/NEJMra061808 (Pubitemid 44427449)
6. Magee J. A., Piskounova E., Morrison S. J., Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012 21 3 283 296 2-s2.0-84858608410 10.1016/j.ccr.2012.03.003
7. Hamburger A. W., Salmon S. E., Primary bioassay of human tumor stem cells. Science 1977 197 4302 461 463 2-s2.0-0017785769
8. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
9. Collins A. T., Berry P. A., Hyde C., Stower M. J., Maitland N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 2005 65 23 10946 10951 2-s2.0-28244472369 10.1158/0008-5472.CAN-05-2018 (Pubitemid 41713363)
10. Yang Z. F., Ho D. W., Ng M. N., Lau C. K., Yu W. C., Ngai P., Chu P. W. K., Lam C. T., Poon R. T. P., Fan S. T., Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008 13 2 153 166 2-s2.0-38549139140 10.1016/j.ccr.2008.01.013 (Pubitemid 351163165)
11. Abbott B. L., Colapietro A.-M., Barnes Y., Marini F., Andreeff M., Sorrentino B. P., Low levels of ABCG2 expression in adult AML blast samples. Blood 2002 100 13 4594 4601 2-s2.0-0037114644 10.1182/blood-2002-01-0271 (Pubitemid 35429703)
12. Zhou S., Schuetz J. D., Bunting K. D., Colapietro A.-M., Sampath J., Morris J. J., Lagutina I., Grosveld G. C., Osawa M., Nakauchi H., Sorrentino B. P., The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine 2001 7 9 1028 1034 2-s2.0-0034795256 10.1038/nm0901-1028 (Pubitemid 32937383)
13. Chiba T., Kita K., Zheng Y.-W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., Taniguchi H., Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006 44 1 240 251 2-s2.0-33745924696 10.1002/hep.21227 (Pubitemid 44049156)
14. Zhou S., Morris J. J., Barnes Y., Lan L., Schuetz J. D., Sorrentino B. P., Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proceedings of the National Academy of Sciences of the United States of America 2002 99 19 12339 12344 2-s2.0-0037125973 10.1073/pnas. 192276999
15. Salmon S. E., Hamburger A. W., Soehnlen B., Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. The New England Journal of Medicine 1978 298 24 1321 1327 2-s2.0-0018097960 (Pubitemid 8357629)
16. Jia Q., Zhang X., Deng T., Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Cellular Reprogramming 2013 15 2 143 150
17. Shi C., Tian R., Wang M., Wang X., Jiang J., Zhang Z., Li X., He Z., Gong W., Qin R., CD44+ CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biology & Therapy 2010 10 11 1182 1190 2-s2.0-79959594835
18. Qiang G. H., Yu D. C., Ding X. W., Expression of ABCG2 in human liver cancer cell lines and its related functions. Chinese Journal 2012 19 146 150
19. Sobin L. H., Wittekind C. H., TNM Classification of Malignant Tumors 2002 6th New York, NY, USA Wiley-Blackwell
20. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L., Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England Journal of Medicine 1996 334 11 693 699 2-s2.0-0345299824 10.1056/NEJM199603143341104 (Pubitemid 26079803)
21. Luo W. H., Jiang C. P., Ding Y. T., Construcion and identification of eukaryotic expression vector pcDNA3. 1 (+)-ABCG2. Journal of Hepatobiliary Surgery 2013 21 137 140
22. Wu F., Yang L.-Y., Li Y.-F., Ou D.-P., Chen D.-P., Fan C., Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 2009 50 6 1839 1850 2-s2.0-73149115105 10.1002/hep.23197
23. Llovet J. M., Schwartz M., Mazzaferro V., Resection and liver transplantation for hepatocellular carcinoma. Seminars in Liver Disease 2005 25 2 181 200 2-s2.0-20344367769 10.1055/s-2005-871198 (Pubitemid 40781071)
24. Llovet J. M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.-F., De Oliveira A. C., Santoro A., Raoul J.-L., Forner A., Schwartz M., Porta C., Zeuzem S., Bolondi L., Greten T. F., Galle P. R., Seitz J.-F., Borbath I., Häussinger D., Giannaris T., Shan M., Moscovici M., Voliotis D., Bruix J., Sorafenib in advanced hepatocellular carcinoma. The New England Journal of Medicine 2008 359 4 378 390 2-s2.0-47949116252 10.1056/NEJMoa0708857
25. Reya T., Morrison S. J., Clarke M. F., Weissman I. L., Stem cells, cancer, and cancer stem cells. Nature 2001 414 6859 105 111 2-s2.0-0035499267 10.1038/35102167 (Pubitemid 33041634)
26. Oishi N., Wang X. W., Novel therapeutic strategies for targeting liver cancer stem cells. International Journal of Biological Sciences 2011 7 5 517 535 2-s2.0-79955764915
27. Dean M., Fojo T., Bates S., Tumour stem cells and drug resistance. Nature Reviews Cancer 2005 5 4 275 284 2-s2.0-16844368698 10.1038/nrc1590 (Pubitemid 40488633)
28. Sun Y. F., Xu Y., Yang X. R., Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 2013 57 1458 1468
29. Ma Y. C., Yang J. Y., Yan L. N., Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. European Journal of Gastroenterology and Hepatology 2013 25 9 1007 1016
30. Benderra Z., Faussat A.-M., Sayada L., Perrot J.-Y., Chaoui D., Marie J.-P., Legrand O., Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias. Clinical Cancer Research 2004 10 23 7896 7902 2-s2.0-9744264044 10.1158/1078-0432.CCR-04-0795 (Pubitemid 39587528)
31. Kamiyama N., Takagi S., Yamamoto C., Kudo T., Nakagawa T., Takahashi M., Nakanishi K., Takahashi H., Todo S., Iseki K., Expression of ABC transporters in human hepatocyte carcinoma cells with cross-resistance to epirubicin and mitoxantrone. Anticancer Research 2006 26 2 885 888 2-s2.0-33645834139
32. Tsunoda S., Okumura T., Ito T., Kondo K., Ortiz C., Tanaka E., Watanabe G., Itami A., Sakai Y., Shimada Y., ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology 2007 71 3-4 251 258 2-s2.0-34548071672 10.1159/000106787 (Pubitemid 47289586)
33. Yoh K., Ishii G., Yokose T., Minegishi Y., Tsuta K., Goto K., Nishiwaki Y., Kodama T., Suga M., Ochiai A., Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clinical Cancer Research 2004 10 5 1691 1697 2-s2.0-12144287061 10.1158/1078-0432.CCR-0937-3 (Pubitemid 38435560)
34. Hang D., Dong H.-C., Ning T., Dong B., Hou D.-L., Xu W.-G., Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Diseases of the Esophagus 2012 25 638 644 2-s2.0-84855614336 10.1111/j.1442-2050.2011.01298.x
35. Omran O. M., The prognostic value of breast cancer resistance protein (BCRB/ABCG2) expression in breast carcinomas. Journal of Environmental Pathology, Toxicology and Oncology 2012 31 367 376
36. Xiang L., Su P., Xia S., Liu Z., Wang Y., Gao P., Zhou G., ABCG2 is associated with HER-2 Expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. Diagnostic Pathology 2011 6 1, article 90 2-s2.0-80053378766 10.1186/1746-1596-6-90
37. Chen Y., Yu D., Zhang H., CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. International Journal of Biological Sciences 2012 8 992 1004
38. Shi G.-M., Xu Y., Fan J., Zhou J., Yang X.-R., Qiu S.-J., Liao Y., Wu W.-Z., Ji Y., Ke A.-W., Ding Z.-B., He Y.-Z., Wu B., Yang G.-H., Qin W.-Z., Zhang W., Zhu J., Min Z.-H., Wu Z.-Q., Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials. Journal of Cancer Research and Clinical Oncology 2008 134 11 1155 1163 2-s2.0-53749088741 10.1007/s00432-008-0407-1
39. Sukowati C. H., Rosso N., Pascut D., Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. BMC Gastroenterol 2012 12, article 160
40. Yang J., Liao D., Chen C., Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells 2013 31 248 258
41. Zhou J., Chen F., Xiao J., Li C., Liu Y., Ding Y., Wan P., Wang X., Huang J., Wang Z., Enhanced functional properties of corneal epithelial cells by coculture with embryonic stem cells via the integrin β 1-FAK-PI3K/Akt pathway. International Journal of Biochemistry and Cell Biology 2011 43 8 1168 1177 2-s2.0-79958734839 10.1016/j.biocel.2011.04.010
42. Morimoto O., Nagano H., Sakon M., Fujiwara Y., Yamada T., Nakagawa H., Miyamoto A., Kondo M., Arai I., Yamamoto T., Ota H., Dono K., Umeshita K., Nakamori S., Sasaki Y., Ishikawa O., Imaoka S., Monden M., Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. Journal of Hepatology 2003 39 2 215 221 2-s2.0-10744224299 10.1016/S0168-8278(03)00233-2 (Pubitemid 36920557)
43. Torzilli P. A., Bourne J. W., Cigler T., A new paradigm for mechanobiological mechanisms in tumor metastasis. Seminars in Cancer Biology 2012 22 385 395
44. Wilson P. M., LaBonte M. J., Lenz H. J., Assessing the in vivo efficacy of biologic antiangiogenic therapies. Cancer Chemotherapy and Pharmacology 2013 71 1 12
45. Chen K., Huang Y. H., Chen J. L., Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacologica Sinica 2013 34 732 740
46. Horst D., Scheel S. K., Liebmann S., Neumann J., Maatz S., Kirchner T., Jung A., The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. Journal of Pathology 2009 219 4 427 434 2-s2.0-72249120793 10.1002/path.2597
47. Naor D., Wallach-Dayan S. B., Zahalka M. A., Sionov R. V., Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Seminars in Cancer Biology 2008 18 4 260 267 2-s2.0-44749091840 10.1016/j.semcancer.2008.03. 015